Is tirzepatide available in pill form?

You've read about oral weight-loss medicines and wondered if Mounjaro comes in a tablet

It's a reasonable question, and it comes up constantly. You might have seen headlines about the Wegovy pill, or a friend mentioned they'd heard a tablet version of tirzepatide was coming. The short answer: those are two separate things. The Wegovy pill is oral semaglutide (a different molecule) and it received MHRA approval in June 2026 as the first oral GLP-1 medicine licensed for weight management in the UK. Tirzepatide, sold here as Mounjaro, remains injection-only.

Eli Lilly, the company behind Mounjaro, is researching an oral tirzepatide formulation. Early-phase clinical work has been reported in the scientific literature, but no product has completed the trials needed for a UK regulatory submission, and the MHRA has not announced any approval timeline. If you want to explore when a broader UK tirzepatide rollout (including any oral version) might happen, the honest summary is that it remains speculative for now.

There is a separate question worth clearing up: Rybelsus is an oral semaglutide tablet, but it is licensed for type 2 diabetes management, not weight loss. It uses the same molecule as Wegovy but at different doses and for a different clinical purpose. These distinctions matter, because taking a medicine outside its licensed indication is not something a responsible prescriber would arrange. The Wegovy tablet (with its own dosing schedule up to a 25mg maintenance dose) is the oral weight-loss option that holds a UK licence today.

Why oral GLP-1 delivery is technically harder than it sounds

Proteins and peptides like tirzepatide are broken down in the stomach before they can reach the bloodstream, which is why the injection bypasses digestion entirely and delivers the medicine reliably into subcutaneous tissue. Getting a peptide to survive the gut, cross the intestinal lining, and reach circulation in therapeutic quantities is a genuine formulation challenge.

Oral semaglutide (the Wegovy pill) solves part of this by pairing semaglutide with an absorption enhancer called SNAC, which protects the molecule and promotes absorption in the stomach lining. It works, but it requires a strict morning routine: the tablet must be taken first thing, on an empty stomach, with a small amount of plain water, and nothing else (no coffee, no food, no other tablets) for at least 30 minutes afterwards. Think of it as the tablet that has to go on the bedside table rather than the kitchen shelf. A different absorption problem may explain why an oral tirzepatide equivalent has taken longer to develop: tirzepatide's dual-receptor action involves a slightly larger and more complex molecule.

For people who find injections difficult, the question of whether Mounjaro will ever come as a tablet is understandable. Right now, injecting Mounjaro is straightforward: the KwikPen delivers one dose a week into the abdomen, thigh or upper arm. Many people find the routine much simpler than expected. The pen stays in the fridge door between weekly doses, and each injection takes seconds.

What this means if you're deciding between injection and tablet today

If you'd genuinely prefer a tablet to an injection, the licensed oral option available in the UK right now is the Wegovy pill. In its phase 3 OASIS 4 trial, participants achieved around 13.6% average weight loss over 64 weeks alongside lifestyle changes, rising to approximately 17% among those who adhered fully to treatment, a result worth considering, though tirzepatide's injectable form produced around 20 to 21% average weight reduction at its highest dose in the SURMOUNT-1 trial, published in the New England Journal of Medicine.

The right choice depends on your health history, any medicines you already take, your daily routine, and your clinical assessment, not just the delivery format. Both are prescription-only medicines, and a prescriber reviews all of this before recommending anything. You can read more about tirzepatide as a treatment and how it compares with other options, or look at the full range of weight-loss treatments we support at nume.

If you're considering Mounjaro specifically, Mounjaro's availability and how to access it in the UK is covered in detail elsewhere. For anyone curious about whether any oral tirzepatide is accessible right now, the answer as of this writing is no, but staying across MHRA announcements is how you'll know when that changes. You can also learn how the online prescription process for Mounjaro works through a regulated UK pharmacy if the injection route is something you'd like to explore. Our clinical team profile at our lead prescriber's page gives a sense of who actually reviews consultations at nume.

Starting any licensed weight-loss medicine is a clinical decision. If you'd like a prescriber to look at your situation, start your free consultation with nume and get a same-day review from a GPhC-registered independent prescriber.